Femasys (FEMY) Cost of Revenue (2020 - 2025)
Femasys (FEMY) reported Cost of Revenue of $158171.0 for Q2 2025, down 83.78% on a YoY basis from $975190.0 in Q2 2024, and down 82.59% quarter-over-quarter from $908567.0 in Q1 2025.
Femasys (FEMY) Cost of Revenue (2020 - 2025) Analysis & Trends
Femasys has reported Cost of Revenue for 6 years, with the latest figure at $158171.0 in Q2 2025.
- For the quarter ending Q2 2025, Cost of Revenue fell 83.78% year-over-year to $158171.0; the trailing twelve-month figure through Jun 2025 stood at $3.8 million (up 198.08% YoY), and the FY2025 full-year result was $4.4 million, up 10.26% from the prior year.
- Cost of Revenue for Q2 2025 stood at $158171.0, down from $908567.0 in the prior quarter.
- The five-year high for Cost of Revenue was $1.6 million in Q3 2024, with the low at -$64609.0 in Q4 2023.
- Historically, Cost of Revenue has averaged $344066.2 across 5 years, with a median of $116572.0 in 2022.
- Annual changes were most pronounced in 2023 — Cost of Revenue sank 175.6% — and 2024, when it soared 2118.01%.
- Femasys' Cost of Revenue stood at $282453.0 in 2021, then tumbled by 69.74% to $85459.0 in 2022, then slumped by 175.6% to -$64609.0 in 2023, then jumped by 1929.91% to $1.2 million in 2024, then tumbled by 86.62% to $158171.0 in 2025.
- The last three Cost of Revenue figures came in at $158171.0 (Q2 2025), $908567.0 (Q1 2025), and $1.2 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 940.30 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.56 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 5.51 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 540.43 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 548.50 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 64.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 346.10 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 303.50 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 1.81 Bn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 158,171.00 |
| Jun 30, 2025 | 158,171.00 |
| Mar 31, 2025 | 908,567.00 |
| Mar 31, 2025 | 908,567.00 |
| Dec 31, 2024 | 1.18 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 975,190.00 |
| Jun 30, 2024 | 975,190.00 |
| Mar 31, 2024 | 300,487.00 |
| Mar 31, 2024 | 300,487.00 |
| Dec 31, 2023 | -64,609.00 |
| Dec 31, 2023 | -64,609.00 |
| Sep 30, 2023 | 70,883.00 |
| Sep 30, 2023 | 70,883.00 |
| Jun 30, 2023 | 110,469.00 |
| Jun 30, 2023 | 110,469.00 |
| Mar 31, 2023 | 105,120.00 |
| Mar 31, 2023 | 105,120.00 |